Xbrane Data Sets Up EU And US Ranibizumab Filings

Filing Dates Confirmed For Xlucane Biosimilar Of Lucentis After Phase III Results

 
• By David Wallace
  
US EU Flags Gears Europe
EU and US Ranibizumab filings are in the works for Xbrane • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products